Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma ; volume:10 ; number:5 ; year:2021 ; pages:473-484 ; extent:12
Liver cancer ; 10, Heft 5 (2021), 473-484 (gesamt 12)
- Creator
-
Koroki, Keisuke
Kanogawa, Naoya
Maruta, Susumu
Ogasawara, Sadahisa
Iino, Yotaro
Obu, Masamichi
Okubo, Tomomi
Itokawa, Norio
Maeda, Takahiro
Inoue, Masanori
Haga, Yuki
Seki, Atsuyoshi
Okabe, Shinichiro
Koma, Yoshihiro
Azemoto, Ryosaku
Atsukawa, Masanori
Itobayashi, Ei
Ito, Kenji
Sugiura, Nobuyuki
Mizumoto, Hideaki
Unozawa, Hidemi
Iwanaga, Terunao
Sakuma, Takafumi
Fujita, Naoto
Kanzaki, Hiroaki
Kobayashi, Kazufumi
Kiyono, Soichiro
Nakamura, Masato
Saito, Tomoko
Kondo, Takayuki
Suzuki, Eiichiro
Ooka, Yoshihiko
Nakamoto, Shingo
Tawada, Akinobu
Chiba, Tetsuhiro
Arai, Makoto
Kanda, Tatsuo
Maruyama, Hitoshi
Kato, Jun
Kato, Naoya
- DOI
-
10.1159/000515552
- URN
-
urn:nbn:de:101:1-2021101400290901885639
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Koroki, Keisuke
- Kanogawa, Naoya
- Maruta, Susumu
- Ogasawara, Sadahisa
- Iino, Yotaro
- Obu, Masamichi
- Okubo, Tomomi
- Itokawa, Norio
- Maeda, Takahiro
- Inoue, Masanori
- Haga, Yuki
- Seki, Atsuyoshi
- Okabe, Shinichiro
- Koma, Yoshihiro
- Azemoto, Ryosaku
- Atsukawa, Masanori
- Itobayashi, Ei
- Ito, Kenji
- Sugiura, Nobuyuki
- Mizumoto, Hideaki
- Unozawa, Hidemi
- Iwanaga, Terunao
- Sakuma, Takafumi
- Fujita, Naoto
- Kanzaki, Hiroaki
- Kobayashi, Kazufumi
- Kiyono, Soichiro
- Nakamura, Masato
- Saito, Tomoko
- Kondo, Takayuki
- Suzuki, Eiichiro
- Ooka, Yoshihiko
- Nakamoto, Shingo
- Tawada, Akinobu
- Chiba, Tetsuhiro
- Arai, Makoto
- Kanda, Tatsuo
- Maruyama, Hitoshi
- Kato, Jun
- Kato, Naoya
Other Objects (12)
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy
Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma
Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy
Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma
Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma
Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
Hepatocellular Carcinoma Showing Pathological Complete Response to Lenvatinib Monotherapy
Sorafenib versus lenvatinib-based sequential systemic therapy for advanced hepatocellular carcinoma: a real-world analysis
Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report
Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma